GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Smith & Nephew Snats, Inc. (SNN) [hlAlert]

Rating:
Outperform
SNN
up 166.21 %

Smith & Nephew Snats, Inc. (SNN) rated Outperform by Credit Suisse

Posted on: Monday,  Jan 26, 2009  8:25 AM ET by Credit Suisse

Credit Suisse rated Outperform Smith & Nephew Snats, Inc. (NYSE: SNN) on 01/26/2009, when the stock price was $13.32.
Since then, Smith & Nephew Snats, Inc. has gained 166.21% as of 12/07/2015's recent price of $35.47.
If you would have followed this Credit Suisse's recommendation on SNN, you would have gained 166.21% of your investment in 2506 days.

Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world

Excellence in equity and fixed income research is a hallmark of Credit Suisse. Globally, our equity research analysts provide in-depth coverage of over 2,500 companies and engage in a knowledge-sharing, value added culture that has yielded the most insightful product for our customers and tremendous competitive results. Additionally, Credit Suisse's powerful macro-economic and debt strategy teams integrate the bank's comprehensive company research with keen market perspectives of the ever-shifting investment terrain.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/26/2009 8:25 AM Buy
None
13.32
as of 12/31/2009
1 Week up  11.65 %
1 Month up  17.48 %
3 Months up  24.71 %
1 YTD up  68.59 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy